Article may be outdated

This article is 46 days old. Some details may have changed since publication.

nature.com·4 min read·hard

Postdiagnostic pretreatment risk stratification for chondrosarcoma survival using routinely available registry variables: a SEER-based temporal validation study

W
Wang, Qiong
Postdiagnostic pretreatment risk stratification for chondrosarcoma survival using routinely available registry variables: a SEER-based temporal validation study
✦AI Summary

Researchers developed and validated a risk-stratification framework for predicting survival outcomes in chondrosarcoma patients using registry data. The study demonstrates that specific clinical variables can effectively categorize patients into high-risk groups.

Why it matters

Improving prognostic accuracy for rare cancers like chondrosarcoma helps clinicians tailor treatment plans and improve patient survival rates.

✦Dive DeeperCreate a free account to unlock

Scientific Reports ( 2026 ) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealth
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in